Cytidine deaminase enzyme activity is a predictive biomarker in gemcitabine-treated cancer patients.

Autor: Abbaspour, Alireza1,2 (AUTHOR), Dehghani, Mehdi3,4 (AUTHOR), Setayesh, Mahtab1,2 (AUTHOR), Tavakkoli, Marjan1 (AUTHOR), Rostamipour, Hossein Ali5 (AUTHOR), Ghorbani, Marziyeh6 (AUTHOR), Ramzi, Mani3,4 (AUTHOR), Omidvari, Shapour7,8 (AUTHOR), Moosavi, Fatemeh1 (AUTHOR), Firuzi, Omidreza1 (AUTHOR) firuzio@sums.ac.ir
Zdroj: Cancer Chemotherapy & Pharmacology. Dec2023, Vol. 92 Issue 6, p475-483. 9p.
Databáze: Academic Search Ultimate
Externí odkaz: